Zhong Guo Zheng Quan Bao - Zhong Zheng Wang·2026-01-14 00:34Core Viewpoint - China Everbright Bank has announced several related party transactions involving credit facilities and loans to companies controlled by its parent, China Everbright Group, totaling RMB 31.54 billion over the past 12 months, which exceeds 0.5% of the bank's latest audited net assets [3][5][10]. Summary by Sections Transaction Overview - The bank has approved a comprehensive credit limit of RMB 354 million for Jiasitang Pharmaceutical Co., Ltd. with a term of 24 months [2][5]. - A bilateral non-committed revolving loan of RMB 500 million has been approved for Everbright Securities International with a term of 360 days [2][6]. - A comprehensive credit limit of RMB 1.4 billion has been approved for Everbright Jinou Asset Management Co., Ltd. with a term of 3 years, along with a single batch credit limit of RMB 900 million for 24 months [2][6]. Related Party Transactions - The transactions with Jiasitang Pharmaceutical, Everbright Securities International, and Everbright Jinou are classified as related party transactions as they are controlled by China Everbright Group [2][7]. - The total amount of related party transactions with China Everbright Group and its subsidiaries in the past 12 months is RMB 31.54 billion, excluding previously disclosed transactions [3][5]. Approval Process - The transactions with Jiasitang Pharmaceutical and Everbright Securities International have been filed with the board's related party transaction control committee and do not require further approval from the board or shareholders [3][11]. - The transaction with Everbright Jinou has been reviewed and approved by the board's related party transaction control committee and independent directors, and does not require shareholder approval [3][11]. Financial Impact - The related party transactions are considered normal business operations for the bank and are not expected to have a significant impact on its financial condition [10][12].